Weight-loss and diabetes drugs like Ozempic, Wegovy, Mounjaro or Zepbound appear to help people battle alcoholism and opioid ...

Lilly has been solidly investing in research and development (R&D) throughout 2024. In April, the company announced the ...

The U.S. Food and Drug Administration (FDA) is rethinking its decision to remove popular weight-loss and diabetes drugs from ...

The case that Ozempic (NVO) and other GLP-1 medications could help people with substance use disorders is getting stronger.

In that spirit, let's consider two biotech companies that could potentially deliver incredible returns next year: Recursion ...

The drugmaker's financial results are also impressive, spearheaded by tirzepatide, a therapy for diabetes and obesity that is ...

In response to a lawsuit, the FDA has said that it will reevaluate its previous decision to remove tirzepatide from its ...

Democrat Wesley Harris and Republican Brad Briner are vying to be the state’s next treasurer, overseeing the management of ...

You’ve probably heard of the semaglutide brand names Ozempic®, Wegovy, and Rybelsus. You may have even heard about affordable options like compounded semaglutide.

Not everybody loses the same amount of weight on medications such as Ozempic and Saxenda—treatment indication, dosage, and ...

The logic suggested by the Lilly trial is the opposite, however. It proposes that being overweight is a primary cause of ...

Hims stock has rallied almost 22% this week on enthusiasm after the FDA said it will allow compounded versions of Lilly's ...